1. Home
  2. MBOT vs OPP Comparison

MBOT vs OPP Comparison

Compare MBOT & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBOT
  • OPP
  • Stock Information
  • Founded
  • MBOT 2010
  • OPP 2010
  • Country
  • MBOT United States
  • OPP United States
  • Employees
  • MBOT N/A
  • OPP N/A
  • Industry
  • MBOT Medical/Dental Instruments
  • OPP Finance/Investors Services
  • Sector
  • MBOT Health Care
  • OPP Finance
  • Exchange
  • MBOT Nasdaq
  • OPP Nasdaq
  • Market Cap
  • MBOT 184.8M
  • OPP 208.6M
  • IPO Year
  • MBOT N/A
  • OPP N/A
  • Fundamental
  • Price
  • MBOT $3.34
  • OPP $8.51
  • Analyst Decision
  • MBOT Strong Buy
  • OPP
  • Analyst Count
  • MBOT 1
  • OPP 0
  • Target Price
  • MBOT $12.00
  • OPP N/A
  • AVG Volume (30 Days)
  • MBOT 7.2M
  • OPP 108.0K
  • Earning Date
  • MBOT 11-12-2025
  • OPP 01-01-0001
  • Dividend Yield
  • MBOT N/A
  • OPP 14.41%
  • EPS Growth
  • MBOT N/A
  • OPP N/A
  • EPS
  • MBOT N/A
  • OPP N/A
  • Revenue
  • MBOT N/A
  • OPP N/A
  • Revenue This Year
  • MBOT N/A
  • OPP N/A
  • Revenue Next Year
  • MBOT $728.02
  • OPP N/A
  • P/E Ratio
  • MBOT N/A
  • OPP N/A
  • Revenue Growth
  • MBOT N/A
  • OPP N/A
  • 52 Week Low
  • MBOT $0.85
  • OPP $7.26
  • 52 Week High
  • MBOT $4.67
  • OPP $8.83
  • Technical
  • Relative Strength Index (RSI)
  • MBOT 47.14
  • OPP 34.23
  • Support Level
  • MBOT $3.16
  • OPP $8.70
  • Resistance Level
  • MBOT $4.25
  • OPP $8.68
  • Average True Range (ATR)
  • MBOT 0.40
  • OPP 0.07
  • MACD
  • MBOT -0.10
  • OPP -0.03
  • Stochastic Oscillator
  • MBOT 11.59
  • OPP 0.26

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.

RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.

Share on Social Networks: